Dipyridamole dispersible tablets

It can inhibit platelet aggregation and prevent thrombosis.

The main ingredient is dipyridamole. Its chemical name is 2,2',2,2'-[4,8-dipiperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl]bis(nitrogen)-tetraethanol

This product is white tablets.

For the prevention of thromboembolic disease.

Oral administration: 25-50 mg each time, 3 times a day, before meals. Or as directed by a doctor.

Adverse reactions are mild and short-lived at therapeutic doses, and most of the initial side effects disappear after long-term use. Common adverse reactions include dizziness, headache, vomiting, diarrhea, flushing, rash and itching, and rarely angina and liver dysfunction. Persistent or intolerable adverse reactions are rare and may disappear after discontinuation of the drug. In post-marketing clinical reports, rare adverse reactions include laryngeal edema, fatigue, discomfort, paresthesia, myalgia, arthritis, nausea, indigestion, hepatitis, cholelithiasis, palpitations, and baldness.

It is contraindicated for those who are allergic to this product.

Precautions for children: The safety and efficacy of the drug for children under 12 years old have not been determined. Precautions for pregnancy and lactation: No appropriate controlled studies have been conducted in pregnant women, and it should only be used in pregnant women when necessary. Dipyridamole is excreted in human breast milk, so breastfeeding women should use it with caution. Precautions for the elderly: Not yet clear.

Not yet clear.

Keep away from light and store in a sealed container.

25mg

24 months

Beijing Juneng Pharmaceutical Co., Ltd.

• Founded in:

  1997-03-17

• Address:

  No. 3, Yongchang North Road, Beijing Economic and Technological Development Zone, Beijing

• Tax NO.:

  911103026337907787

• Registered Funds:

  14 million yuan

• Email:

  Log in to view